Antibiotic Stewardship

Study examines the use of fecal microbiota transplantation versus oral vancomycin for primary treatment of Clostridioides difficile infection.

The session will provide evidence-based advice to encourage appropriate antimicrobial use.

With increased resistance genes in the environment, our exposure to a treatment-resistant disease is growing, researchers say.

Ferring’s Rebyota is indicated for the prevention of recurrence of Clostridioides difficile infection in adults, following antibiotic treatment for recurrent C. difficile.

Webinar featuring Canadian experts will go over recommended change from intravenous to oral antibiotic treatment for these infections.

Quebec revises guidance to promote the judicious use of invasive and non-invasive tests, and the optimal use of antibiotics in the treatment of this infection.

Clarifying who doesn’t need prophylaxis opens door for RCT candidates for MV140 vaccine.

Already in use in Europe, the vaccine reduces the number of urinary tract infection recurrences in significant numbers of women.